دورية أكاديمية
Open PHACTS computational protocols for in silico target validation of cellular phenotypic screens: knowing the knowns.
| العنوان: | Open PHACTS computational protocols for in silico target validation of cellular phenotypic screens: knowing the knowns. |
|---|---|
| المؤلفون: | Digles D; Department of Pharmaceutical Chemistry , University of Vienna , Pharmacoinformatics Research Group , Althanstraße 14 , 1090 Wien , Austria . Email: daniela.digles@univie.ac.at., Zdrazil B; Department of Pharmaceutical Chemistry , University of Vienna , Pharmacoinformatics Research Group , Althanstraße 14 , 1090 Wien , Austria . Email: daniela.digles@univie.ac.at., Neefs JM; Janssen Research & Development , Turnhoutseweg 30 , B-2340 Beerse , Belgium . Email: ejacoby@its.jnj.com., Van Vlijmen H; Janssen Research & Development , Turnhoutseweg 30 , B-2340 Beerse , Belgium . Email: ejacoby@its.jnj.com., Herhaus C; Merck KGaA, Merck Serono R&D , Computational Chemistry , Frankfurter Straße 250 , 64293 Darmstadt , Germany., Caracoti A; BIOVIA , a Dassault Systèmes brand , 334 Cambridge Science Park , Cambridge CB4 0WN , UK., Brea J; Grupo BioFarma-USEF , Departamento de Farmacología , Facultad de Farmacia , Campus Universitario Sur s/n , 15782 Santiago de Compostela , Spain., Roibás B; Grupo BioFarma-USEF , Departamento de Farmacología , Facultad de Farmacia , Campus Universitario Sur s/n , 15782 Santiago de Compostela , Spain., Loza MI; Grupo BioFarma-USEF , Departamento de Farmacología , Facultad de Farmacia , Campus Universitario Sur s/n , 15782 Santiago de Compostela , Spain., Queralt-Rosinach N; Research Programme on Biomedical Informatics (GRIB) , Hospital del Mar Medical Research Institute (IMIM) , Department of Experimental and Health Sciences , Universitat Pompeu Fabra , C/Dr Aiguader 88 , E-08003 Barcelona , Spain., Furlong LI; Research Programme on Biomedical Informatics (GRIB) , Hospital del Mar Medical Research Institute (IMIM) , Department of Experimental and Health Sciences , Universitat Pompeu Fabra , C/Dr Aiguader 88 , E-08003 Barcelona , Spain., Gaulton A; European Molecular Biology Laboratory , European Bioinformatics Institute (EMBL-EBI) , Wellcome Genome Campus , Hinxton , Cambridge CB10 1SD , UK., Bartek L; GlaxoSmithKline , Medicines Research Centre , Stevenage SG1 2NY , UK., Senger S; GlaxoSmithKline , Medicines Research Centre , Stevenage SG1 2NY , UK., Chichester C; Swiss Institute of Bioinformatics , CALIPHO Group , CMU Rue Michel-Servet 1 , 1211 Geneva 4 , Switzerland ; Nestlé Institute of Health Sciences SA , EPFL Innovation Park, Bâtiment H , 1015 Lausanne , Switzerland., Engkvist O; Chemistry Innovation Centre , Discovery Sciences , AstraZeneca R&D Gothenburg , SE-431 83 Mölndal , Sweden., Evelo CT; Department of Bioinformatics - BiGCaT , P.O. Box 616 , UNS50 Box19 , NL-6200MD Maastricht , The Netherlands., Franklin NI; Open Innovation Drug Discovery , Discovery Chemistry Eli Lilly and Company , Lilly Corporate Center , DC 1920 , Indianapolis , IN 46285 , USA., Marren D; Eli Lilly and Company Ltd. , Lilly Research Centre , Erl Wood Manor, Sunninghill Road , Windlesham , Surrey GU20 6PH , England , UK., Ecker GF; Department of Pharmaceutical Chemistry , University of Vienna , Pharmacoinformatics Research Group , Althanstraße 14 , 1090 Wien , Austria . Email: daniela.digles@univie.ac.at., Jacoby E; Janssen Research & Development , Turnhoutseweg 30 , B-2340 Beerse , Belgium . Email: ejacoby@its.jnj.com. |
| المصدر: | MedChemComm [Medchemcomm] 2016 Jun 01; Vol. 7 (6), pp. 1237-1244. Date of Electronic Publication: 2016 May 11. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101531525 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2040-2503 (Print) Linking ISSN: 20402503 NLM ISO Abbreviation: Medchemcomm Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Cambridge : Royal Society of Chemistry, 2010-2019. |
| مستخلص: | Phenotypic screening is in a renaissance phase and is expected by many academic and industry leaders to accelerate the discovery of new drugs for new biology. Given that phenotypic screening is per definition target agnostic, the emphasis of in silico and in vitro follow-up work is on the exploration of possible molecular mechanisms and efficacy targets underlying the biological processes interrogated by the phenotypic screening experiments. Herein, we present six exemplar computational protocols for the interpretation of cellular phenotypic screens based on the integration of compound, target, pathway, and disease data established by the IMI Open PHACTS project. The protocols annotate phenotypic hit lists and allow follow-up experiments and mechanistic conclusions. The annotations included are from ChEMBL, ChEBI, GO, WikiPathways and DisGeNET. Also provided are protocols which select from the IUPHAR/BPS Guide to PHARMACOLOGY interaction file selective compounds to probe potential targets and a correlation robot which systematically aims to identify an overlap of active compounds in both the phenotypic as well as any kinase assay. The protocols are applied to a phenotypic pre-lamin A/C splicing assay selected from the ChEMBL database to illustrate the process. The computational protocols make use of the Open PHACTS API and data and are built within the Pipeline Pilot and KNIME workflow tools. |
| References: | Biochim Biophys Acta. 2013 Feb;1829(2):211-8. (PMID: 23246602) Clin Pharmacol Ther. 2013 Apr;93(4):299-301. (PMID: 23511784) Nat Rev Drug Discov. 2011 Jun 24;10(7):507-19. (PMID: 21701501) J Chem Inf Model. 2011 Sep 26;51(9):2440-8. (PMID: 21834535) Database (Oxford). 2015 Apr 15;2015:bav028. (PMID: 25877637) Nucleic Acids Res. 2016 Jan 4;44(D1):D1054-68. (PMID: 26464438) Bioinformatics. 2016 Jul 15;32(14):2236-8. (PMID: 27153650) Drug Discov Today. 2015 Apr;20(4):422-34. (PMID: 25463034) Angew Chem Int Ed Engl. 2013 Mar 4;52(10):2744-92. (PMID: 23418026) Front Pharmacol. 2014 Dec 01;5:264. (PMID: 25520660) PLoS One. 2015 Jul 15;10(7):e0130796. (PMID: 26177200) J Proteomics. 2011 Nov 18;74(12):2554-74. (PMID: 21621023) Bioinformatics. 2014 May 1;30(9):1338-9. (PMID: 24413672) Bioorg Med Chem Lett. 2015 Aug 15;25(16):3079-86. (PMID: 26115575) Drug Discov Today. 2015 Jun;20(6):652-8. (PMID: 25596550) Nucleic Acids Res. 2013 Jan;41(Database issue):D456-63. (PMID: 23180789) Nat Genet. 2000 May;25(1):25-9. (PMID: 10802651) Nucleic Acids Res. 2014 Jan;42(Database issue):D1083-90. (PMID: 24214965) J Cheminform. 2015 Apr 15;7:15. (PMID: 25926892) Nucleic Acids Res. 2015 Jan;43(Database issue):D1049-56. (PMID: 25428369) Nat Chem Biol. 2008 Jan;4(1):59-68. (PMID: 18066055) Drug Discov Today. 2015 Apr;20(4):450-7. (PMID: 25572406) Nucleic Acids Res. 2016 Jan 4;44(D1):D1220-8. (PMID: 26582922) Nucleic Acids Res. 2010 Jul;38(Web Server issue):W677-82. (PMID: 20501605) Drug Discov Today. 2012 Apr;17(7-8):325-35. (PMID: 22269136) Drug Discov Today. 2012 Nov;17(21-22):1188-98. (PMID: 22683805) Drug Discov Today. 2016 Jan;21(1):82-89. (PMID: 26272035) Nat Rev Drug Discov. 2014 Aug;13(8):577-87. (PMID: 25033734) Nucleic Acids Res. 2016 Jan 4;44(D1):D488-94. (PMID: 26481357) ACS Med Chem Lett. 2014 Jul 14;5(9):963-7. (PMID: 25221649) J Cheminform. 2015 May 30;7:24. (PMID: 26064191) Nat Biotechnol. 2016 Jan;34(1):95-103. (PMID: 26501955) ACS Chem Biol. 2014 Jul 18;9(7):1622-31. (PMID: 24802392) |
| تواريخ الأحداث: | Date Created: 20161025 Latest Revision: 20240326 |
| رمز التحديث: | 20240326 |
| مُعرف محوري في PubMed: | PMC5063042 |
| DOI: | 10.1039/c6md00065g |
| PMID: | 27774140 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2040-2503 |
|---|---|
| DOI: | 10.1039/c6md00065g |